Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27333181 | 0.88 | KDM4E (0.33) | KDM4EGAAMAPTCHRNB4CHRNA3 | |
| SCHEMBL27711035 | 0.81 | BRD4 (0.38) | — | |
| SCHEMBL27328289 | 0.81 | DAO (0.35) | CYP19A1 | |
| SCHEMBL27328163 | 0.77 | GAA (0.43) | KDM4EGAAMAPTCYP19A1 | |
| SCHEMBL27587569 | 0.77 | CHRNB4 (0.39) | GAAMAPTCHRNB4CHRNA3 | |
| SCHEMBL27338995 | 0.76 | — | — | |
| SCHEMBL27701185 | 0.76 | HTR3A (0.34) | GAA | |
| SCHEMBL10494909 | 0.76 | AR (0.40) | KDM4EGAAMAPTCHRNB4CHRNA3 | |
| SCHEMBL28770518 | 0.73 | PPARG (0.40) | — | |
| SCHEMBL28484421 | 0.72 | CA9 (0.34) | KDM4EGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924247-A | Triazole derivative with liver cancer cell activity inhibiting function, and preparation method and application thereof | 河南科技大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-101379048-B | Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents | MITSUBISHI TANABE PHARMA CORP | 2012-03-21 | — | — | CN | disclosed |
| CN-101730680-A | Has 5-HT 64 ' the compound that replaces of receptor affinity | MEMORY PHARM CORP | 2010-06-09 | — | — | CN | disclosed |
| CN-101379048-A | Benzo oxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents | MITSUBISHI TANABE PHARMA CORP (JP) | 2009-03-04 | — | — | CN | disclosed |